Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil for Excessive Sleepiness in Jet Lag Disorder
NCT00758498Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Sep 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of armodafinil in jet lag disorder, sponsored by Cephalon, Inc.. Started Sep 2008; status: completed.
02
Drugs
armodafinil
03
Conditions
jet lag disorder
Beyond the preview
Go deeper on NCT00758498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00758498.